ELCO Management’s 2seventy bio TSVT Stock Holding History

ELCO Management’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,051	Closed	-$66.8K	–	148
2023 Q3	$66.8K	Buy	+17,051	New	+$112K	0.05%	130

Other funds holding TSVT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

ELCO Management's TSVT Position: Q4 2023 in Review

ELCO Management sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 17,051 shares — an estimated $66.8K sold.

ELCO Management first reported a position in TSVT in Q3 2023 and held it in 1 quarter. The position peaked at $66.8K in Q3 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

ELCO Management reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
ELCO Management sold 17,051 2seventy bio shares in Q4 2023, an estimated $66.8K.
ELCO Management first reported a position in 2seventy bio in Q3 2023 and held it in 1 quarter.
ELCO Management's 2seventy bio position peaked at $66.8K in Q3 2023.
116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on ELCO Management's 13F filing for Q4 2023, filed 14 Feb 2024.